Europska Unija - hrvatski - EMA (European Medicines Agency)

acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotska sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

acino france sas, centre specialité pharmaceutiques (csp), 76-78 avenue du midi cs 30077, cournon d'auvergne cedex, francuska - ksilometazolinklorid ipratropijev bromid hidrat - sprej za nos, otopina - urbroj: 1 ml otopine sadrži 0,5 mg ksilometazolinklorida i 0,6 mg ipratropijevog bromida u obliku ipratropijevog bromida hidrata

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

berlin-chemie ag, glienicker weg 125, berlin, njemačka - ibuprofen - filmom obložena tableta - 400 mg - urbroj: jedna filmom obložena tableta sadrži 400 mg ibuprofena

Hrvatska - hrvatski - Ecolab

ecolab deutschland gmbh -

Europska Unija - hrvatski - EMA (European Medicines Agency)

bayer ag - riociguat - hipertenzija, plućna - antihipertenzivi za plućnu arterijsku hipertenziju - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. učinkovitost je dokazana u populaciji uh uključujući etiologija idiopatskom ili nasljedne ili uh uh, povezane s bolestima vezivnog tkiva . paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.

Europska Unija - hrvatski - EMA (European Medicines Agency)

bayer ag - radium (223ra) dichloride - prostatske neoplazme - terapeutski radiofarmaceutski pripravci - xofigo je indiciran za liječenje odraslih osoba s karcinomom prostate otpornih na kastriranje, simptomatskim koštanim metastazama i bez poznatih visceralnih metastaza.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

bayer d.o.o., radnička cesta 80, zagreb - moxifloxacinum - filmom obložena tableta - 400 mg - urbroj: jedna filmom obložena tableta sadrži 400 mg moksifloksacina u obliku moksifloksacinklorida

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

bayer d.o.o., radnička cesta 80, zagreb - moxifloxacinum - otopina za infuziju - 400 mg/250 ml - urbroj: 1 ml otopine za infuziju sadržava 1,6 mg moksifloksacina u obliku moksifloksacinklorida

Europska Unija - hrvatski - EMA (European Medicines Agency)

bayer ag - vericiguat - zastoj srca - srčana terapija - treatment of symptomatic chronic heart failure.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

bayer ag - koncentrirana suspenzija (sc) - fluopikolid (62,5 g/l), propamokarb (625 g/l)